| KOTAK NIFTY MNC ETF
An open ended scheme replicating/tracking NIFTY MNC Index
NSE Symbol - KOTAKMNC
An open ended scheme replicating/tracking NIFTY MNC Index
NSE Symbol - KOTAKMNC
| KOTAK NIFTY MNC ETF
An open ended scheme replicating/tracking NIFTY MNC Index
NSE Symbol - KOTAKMNC
An open ended scheme replicating/tracking NIFTY MNC Index
NSE Symbol - KOTAKMNC
 
|
|
|
Investment Objective
The investment objective of the scheme is
to replicate the composition of the NIFTY
MNC Index and to generate returns that are
commensurate with the performance of
the NIFTY MNC Index, subject to tracking
errors. However, there is no assurance or
guarantee that the investment objective of
the scheme will be achieved.
The investment objective of the scheme is
to replicate the composition of the NIFTY
MNC Index and to generate returns that are
commensurate with the performance of
the NIFTY MNC Index, subject to tracking
errors. However, there is no assurance or
guarantee that the investment objective of
the scheme will be achieved.
| Issuer/Instrument | Industry/ Rating |
% to Net Assets |
|---|---|---|
| Equity & Equity Related | ||
| Food Products | 18.45 | |
| Nestle India Ltd. | 9.81 | |
| Britannia Industries Ltd. | 8.64 | |
| Automobiles | 10.93 | |
| Maruti Suzuki India Limited | 10.93 | |
| Diversified FMCG | 10.14 | |
| Hindustan Unilever Ltd. | 10.14 | |
| Electrical Equipment | 6.97 | |
| Siemens Ltd. | 4.42 | |
| ABB India Ltd | 2.55 | |
| Industrial Products | 6.61 | |
| Cummins India Ltd. | 3.31 | |
| SKF India Ltd | 1.73 | |
| Grindwell Norton Ltd. | 1.57 | |
| Diversified Metals | 6.28 | |
| Vedanta Ltd. | 6.28 | |
| Pharmaceuticals and Biotechnology | 5.99 | |
| Abbott India Ltd. | 1.88 | |
| GLAND PHARMA LIMITED | 1.34 | |
| Pfizer Ltd. | 1.02 | |
| GlaxoSmithKline Pharmaceuticals Ltd. | 0.89 | |
| Sanofi India Ltd. | 0.86 | |
| Beverages | 5.81 | |
| United Spirits Ltd. | 3.88 | |
| United Breweries Ltd. | 1.93 | |
| Personal Products | 5.54 | |
| Colgate Palmolive (India ) Ltd. | 3.28 | |
| Procter & Gamble Hygiene and Health Care Ltd. | 2.26 | |
| Cement and Cement Products | 5.00 | |
| Ambuja Cements Ltd. | 5.00 | |
| Auto Components | 4.32 | |
| Bosch Ltd. | 2.47 | |
| Schaeffler India Ltd | 1.85 | |
| IT - Software | 4.11 | |
| Mphasis Ltd | 2.91 | |
| Oracle Financial Services Software Ltd | 1.20 | |
| Agricultural, Commercial and Constr | 3.65 | |
| Ashok Leyland Ltd. | 3.65 | |
| Consumer Durables | 2.64 | |
| Bata India Ltd. | 1.67 | |
| Kansai Nerolac Paints Ltd | 0.97 | |
| Industrial Manufacturing | 1.47 | |
| Honeywell Automation India Ltd. | 1.47 | |
| Diversified | 1.11 | |
| 3M India Ltd. | 1.11 | |
| Telecom - Services | 0.96 | |
| Vodafone Idea Ltd | 0.96 | |
| Equity & Equity Related - Total | 99.98 | |
| Net Current Assets/(Liabilities) | 0.02 | |
| Grand Total | 100.00 | |
NAV
Rs19.393
Available Plans/Options
Regular Plan
| Fund Manager* | Mr. Devender Singhal Mr. Satish Dondapati Mr. Abhishek Bisen |
| Benchmark | NIFTY MNC Index TRI |
| Allotment date | August 05, 2022 |
| AAUM | Rs76.77 crs |
| AUM | Rs78.26 crs |
| Folio count | 553 |
Ratios
| Portfolio Turnover : | 19.83% |
Minimum Investment Amount
Through Exchange: 1 Unit,
Through AMC: 150000 Units
Ideal Investments Horizon: 5 years & above
Load Structure
Entry Load: Nil. (applicable for all plans)
Exit Load:
Nil. (applicable for all plans)
Total Expense Ratio**
Regular: 0.30%
Data as on January 31, 2023
Fund
Benchmark
This product is suitable for investors who are seeking*:
- Long term capital growth
- Investment in stocks comprising the underlying index and endeavours to track the benchmark index
* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
The above risk-o—meter is based on the scheme portfolio as on 31st January 2023. An addendum may be issued or updated on the website for new riskometer
Total Expense Ratio includes applicable B30 fee and GST
Scheme has not completed 6 months since inception